Aclaris Therapeutics to Present at the Jefferies Virtual Healthcare Conference
May 26 2020 - 4:01PM
Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a physician-led
biopharmaceutical company focused on immuno-inflammatory diseases,
today announced that management will present a company overview at
the Jefferies Virtual Healthcare Conference on Wednesday, June 3,
2020 at 1:00 p.m. ET.
A live audio webcast of the presentation may be accessed through
the Events section of Aclaris’ website, www.aclaristx.com. An
archived version of the webcast will be available for 30 days.
About Aclaris Therapeutics, Inc.Aclaris Therapeutics, Inc. is a physician-led
biopharmaceutical company committed to addressing the needs of
patients with immuno-inflammatory diseases who lack satisfactory
treatment options. The company’s diverse and multi-stage portfolio
includes one late-stage investigational drug candidate and a
pipeline powered by a robust R&D engine exploring protein
kinase regulation. For additional information, please visit
www.aclaristx.com and follow Aclaris on LinkedIn or Twitter
@aclaristx.
Aclaris Contactinvestors@aclaristx.com
Aclaris Therapeutics (NASDAQ:ACRS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Aclaris Therapeutics (NASDAQ:ACRS)
Historical Stock Chart
From Apr 2023 to Apr 2024